ECT骨显像联合血清PSA检测诊断前列腺癌骨转移的临床价值

    ECT bone imaging combined with serum PSA in diagnosis of bone metastasis of prostate carcinoma

    • 摘要: 目的:探讨发射型计算机断层摄影(ECT)骨显像联合血清前列腺特异性抗原(PSA)测定在前列腺癌骨转移诊断中的临床价值。方法:对56例前列腺癌患者的ECT骨显像、血清PSA水平与骨转移的关系进行回顾性分析。结果:前列腺癌骨转移发生率为67.8%,骨转移组与非骨转移组的PSA值差异有统计学意义(P<0.01);PSA值与骨转移的程度有一定关系(P<0.01)。结论:ECT骨显像对前列腺癌骨转移有较高的敏感性,对未经治疗的前列腺癌患者,若PSA<10μg/L则骨转移的可能性极小;PSA>100μg/L者,骨转移的可能性极大。当PSA>20μg/L时,应常规进行ECT骨显像检查,可早期、全面地发现前列腺癌骨转移。

       

      Abstract: Objective: To investigate the clinical value of emssion computed tomography(ECT) bone imaging combined with serum prostate specific antigen(PSA) in diagnosing bone metastasis of prostate carcinoma.Methods: Fifty-six cases of prostate carcinoma were reviewed and the correlation between ECT,PSA and bone metastasis was analyzed.Results: The incidence of bone metastasis of prostate carcinoma was 67.8%.The value of PSA between bone metastasis(BM) group and non-BM(NBM) group had significant difference(P<0.01);the value of PSA and the degree of bone metastasis were positively correlated(P<0.01).Conclusions: ECT is highly sensitive to bone metastasis of prostate carcinoma.If PSA is <10 μg/L,the chance of BM is quite small;if PSA is >100 μg/L,LBM is in high suspect.It suggests that if PSA is > 20 μg/L,LECT bone imaging should be performed.

       

    /

    返回文章
    返回